Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -5.21% | 161.91 | 0.0% | $1387.78m | |
| NVAX | Novavax, Inc. | -2.57% | 221.50 | 80.0% | $650.79m | |
| AMGN | Amgen, Inc. | 0.10% | 255.97 | 1.3% | $554.37m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -5.63% | 7.55 | 0.7% | $527.77m | |
| ILMN | Illumina, Inc. | 1.30% | 404.18 | 3.5% | $527.33m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.58% | 499.69 | 2.7% | $447.00m | |
| GILD | Gilead Sciences, Inc. | -1.38% | 65.95 | 1.0% | $437.06m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.10% | 219.18 | 1.9% | $383.57m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.09% | 165.47 | 2.0% | $360.29m | |
| BNTX | BioNTech SE | -1.36% | 149.48 | 0.0% | $336.51m | |
| BIIB | Biogen, Inc. | -0.47% | 269.05 | 1.7% | $246.78m | |
| NBIX | Neurocrine Biosciences, Inc. | -1.79% | 94.85 | 4.9% | $180.78m | |
| EXAS | EXACT Sciences Corp. | -1.93% | 127.53 | 18.4% | $168.47m | |
| CRSP | CRISPR Therapeutics AG | -2.97% | 115.04 | 0.6% | $158.56m | |
| SGEN | Seagen Inc. | -1.02% | 144.01 | 5.8% | $140.14m |
Company Profile
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.